Professor Bucciarelli-Ducci received her undergraduate degree (2001) and postgraduate fellowship in cardiology (2005) from the University of Rome “La Sapienza”, Italy. She then undertook courses and fellowships at Northwestern University in Chicago, University of Zurich, Harvard Medical School, Oxford University and more recently an MSc in Health Economics from LSE. She worked at the Royal Brompton Hospital as a senior CMR clinical and research fellow in 2006-2010 and in 2012 she was awarded a PhD in CMR from the National Heart and Lung Institute, Imperial College. She was appointed a consultant cardiologist at the Bristol Heart Institute and University of Bristol where she was headhunted in 2010 to build the CMR programme. In 2021 she then returned to Royal Brompton and Harefield Hospitals to lead the CMR clinical academic programme at Harefield. She is associate professor at King College London, School of Biomedical Engineering & Imaging. Since 2019 she is also the CEO of the Society for Cardiovascular Magnetic Resonance, the leading international association in the field of CMR with HQ in the USA. Previously, she held leadership positions in the European Association of Cardiovascular Imaging and European Society of Cardiology with whom she continues to have strong collaborations. She is an invited expert by the European Medicines Agency (EMA) of the European Union (on contrast agents) and by the International Atomic Energy Agency (IAEA) of United Nations (on medical imaging without use of radiations). She is in the scientific advisory board of the National Heart Centre Singapore and Centro de Investigaciones Cardiovasculares (CNIC) in Spain. She is the deputy editor of the European Heart Journal (one of the most important cardiology journals worldwide) for the cardiovascular imaging section. She is recipient of numerous prestigious prizes/ awards, including the NHS national Clinical Excellence Award (bronze)(2021), winner Imperial College Alumni Emerging Leaders award (2022), winner Excellence in Education Outstanding Mid-Career Educator Award, European Society of Cardiology (2023), Finalist Wesleyan Prize, Medical Women Federation UK (2017), Winner William Harvey Prize, Italian Society of Cardiology (2011), Finalist Melvin Judkins Young Clinical Imaging Investigator Award, American Heart Association (2010), and others.

John Atherton (MBBS, PhD, FRACP, FCSANZ, FHFA) is a Pre-eminent Staff Specialist and Director of Cardiology at the Royal Brisbane and Women’s Hospital (RBWH) and Professor, Faculty of Medicine, University of Queensland. Professor Atherton was one of four non-European official content reviewers for the 2016 European Society of Cardiology Heart Failure Guidelines and is a European Society of Cardiology Heart Failure Association Ambassador. He chaired the 2018 National Heart Foundation of Australia/ Cardiac Society of Australia and New Zealand (CSANZ) Heart Failure Guidelines, sits on the Therapeutic Guidelines Cardiovascular Expert Group and co-authored the first universal definition of heart failure. Professor Atherton is Data Custodian for the Queensland Cardiac Outcomes Registry (QCOR)- Heart Failure and sits as a Director on the National Cardiac Registry Board. His clinical and research interests include investigating novel methods to detect pre-symptomatic heart disease, heart failure disease management, hypertrophic cardiomyopathy and cardiac genetics.

Christopher M. Kramer, MD, FACC, received his medical degree from the University of California, San Francisco School of Medicine, and completed his residency and chief residency in internal medicine, and fellowship in cardiology at the Hospital of the University of Pennsylvania. His first faculty appointment was at Allegheny General Hospital, then MCP/Hahnemann University School of Medicine, where he directed the cardiology fellowship. He then moved to the University of Virginia School of Medicine, where in 2019 he was named the George A. Beller/Lantheus Medical Imaging Distinguished Professor of Cardiovascular Medicine, Chief of the Division of Cardiovascular Medicine, and Medical Director of the Heart and Vascular Science Line. Kramer's principal research interest has been the application of cardiovascular magnetic resonance (CMR) to the cardiovascular system in clinical and translational studies. Prior to serving as ACC President, Kramer served as President of the Society for Cardiovascular Magnetic Resonance (SCMR), ACC Treasurer and Vice President, Chair of ACC's Imaging Council, and Chair of the Clinical and Integrative Cardiovascular Sciences NIH study section. Kramer was an associate editor at JACC and previously was Executive Editor of JACC: Cardiovascular Imaging. He currently serves on the editorial boards of Circulation, Circulation: Cardiovascular Imaging and Vascular Medicine. Kramer is also a member of the American Society for Clinical Investigation, Association of University Cardiologists and American Association of Physicians. He received the Gold Medal from the Society for Cardiovascular Magnetic Resonance in 2015 and was named a Distinguished Mentor by the ACC in 2021. Chris is joining this year's ASM representing the American College of Cardiology, in his role as President.

Dr Preeti Choudhary is a consultant cardiologist at Westmead, Blacktown and Auburn hospitals as well as at Westmead Private. She sub-specialises in cardiac MRI and adult congenital heart disease. Dr Choudhary trained at Westmead Hospital and subsequently completed a PhD with the University of Sydney at RPA hospital looking at structural and functional sequelae of non-compaction in congenital heart disease. She completed a cardiac MRI fellowship at CMRS, Sydney and subsequently in adult congenital heart disease and cardiac MRI from 2015-2017 at St Bartholomew’s Heart Centre and Great Ormond Street Hospital in London. Dr Choudhary has published extensively related to adult congenital heart disease and cardiac MRI. Dr Choudhary currently serves as the Vice-President for ANZCMR. She is affiliated with the University of Sydney.

A/Prof Rebecca Kozor is a physician-researcher with roles as a consultant cardiologist at Royal North Shore Hospital Sydney and as Associate Professor at the University of Sydney. She has specialist expertise in cardiac imaging, particularly cardiovascular magnetic resonance imaging.

Professor Martin Ugander, MD, PhD, FCSANZ, is since 2019 Professor of Cardiac Imaging at the University of Sydney. One aspect of his research involves using cardiac imaging to develop advanced electrocardiography (ECG) analysis methods, and he is co-founder of the company Advanced ECG Systems.